Published in Proteins on January 05, 2011
Immunity to ricin: fundamental insights into toxin-antibody interactions. Curr Top Microbiol Immunol (2012) 1.28
Resolution of two overlapping neutralizing B cell epitopes within a solvent exposed, immunodominant α-helix in ricin toxin's enzymatic subunit. Toxicon (2012) 1.08
Advances in structure-based vaccine design. Curr Opin Virol (2013) 1.04
Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice. Clin Vaccine Immunol (2013) 0.96
Significant reduction in errors associated with nonbonded contacts in protein crystal structures: automated all-atom refinement with PrimeX. Acta Crystallogr D Biol Crystallogr (2012) 0.95
Structure of RiVax: a recombinant ricin vaccine. Acta Crystallogr D Biol Crystallogr (2011) 0.93
Crystal structures of ricin toxin's enzymatic subunit (RTA) in complex with neutralizing and non-neutralizing single-chain antibodies. J Mol Biol (2014) 0.88
Combination of two candidate subunit vaccine antigens elicits protective immunity to ricin and anthrax toxin in mice. Vaccine (2014) 0.81
Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form. Proc Natl Acad Sci U S A (2015) 0.81
Evaluation of disulfide bond position to enhance the thermal stability of a highly stable single domain antibody. PLoS One (2014) 0.81
Mechanism of protein kinetic stabilization by engineered disulfide crosslinks. PLoS One (2013) 0.80
Progress and challenges associated with the development of ricin toxin subunit vaccines. Expert Rev Vaccines (2016) 0.78
Modulation of toxin stability by 4-phenylbutyric acid and negatively charged phospholipids. PLoS One (2011) 0.78
Novel Ricin Subunit Antigens With Enhanced Capacity to Elicit Toxin-Neutralizing Antibody Responses in Mice. J Pharm Sci (2016) 0.76
Disruption of the putative vascular leak peptide sequence in the stabilized ricin vaccine candidate RTA1-33/44-198. Toxins (Basel) (2013) 0.76
Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies. MAbs (2016) 0.75
Inactivation of Ricin Toxin by Nanosecond Pulsed Electric Fields Including Evidences from Cell and Animal Toxicity. Sci Rep (2016) 0.75
Tissue sulfhydryl groups. Arch Biochem Biophys (1959) 61.89
Implementation of molecular replacement in AMoRe. Acta Crystallogr D Biol Crystallogr (2001) 8.92
MMTSB Tool Set: enhanced sampling and multiscale modeling methods for applications in structural biology. J Mol Graph Model (2004) 5.50
Disulphide bridges in globular proteins. J Mol Biol (1981) 4.06
Engineered disulfide bonds as probes of the folding pathway of barnase: increasing the stability of proteins against the rate of denaturation. Biochemistry (1993) 2.61
Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines. Nat Biotechnol (1997) 2.54
The geometry of the ribosomal polypeptide exit tunnel. J Mol Biol (2006) 2.53
The stability of hydrogen-bonded peptide structures in aqueous solution. C R Trav Lab Carlsberg Chim (1955) 2.45
Conformational stability and activity of ribonuclease T1 with zero, one, and two intact disulfide bonds. J Biol Chem (1988) 2.42
Stabilization of phage T4 lysozyme by engineered disulfide bonds. Proc Natl Acad Sci U S A (1989) 2.17
Is the hydrophobic effect stabilizing or destabilizing in proteins? The contribution of disulphide bonds to protein stability. J Mol Biol (1991) 1.92
Disulfide bonds and the stability of globular proteins. Protein Sci (1993) 1.90
Model building of disulfide bonds in proteins with known three-dimensional structure. Protein Eng (1988) 1.74
Rational engineering of enzyme stability. J Biotechnol (2004) 1.70
Structure-based antigen design: a strategy for next generation vaccines. Trends Biotechnol (2008) 1.68
A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin. Infect Immun (2009) 1.68
The crystallographically determined structures of atypical strained disulfides engineered into subtilisin. J Biol Chem (1986) 1.67
Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo. Hybridoma (1994) 1.62
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin. Clin Exp Immunol (2004) 1.54
A pilot clinical trial of a recombinant ricin vaccine in normal humans. Proc Natl Acad Sci U S A (2006) 1.53
In vivo formation and stability of engineered disulfide bonds in subtilisin. J Biol Chem (1986) 1.51
Ribosome-mediated folding of partially unfolded ricin A-chain. J Biol Chem (2000) 1.51
Disulfide by Design: a computational method for the rational design of disulfide bonds in proteins. Bioinformatics (2003) 1.47
Structure of recombinant ricin A chain at 2.3 A. Protein Sci (1993) 1.41
Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxication. Infect Immun (2006) 1.32
Vaccinology in the genome era. J Clin Invest (2009) 1.31
Finding a new vaccine in the ricin protein fold. Protein Eng Des Sel (2004) 1.29
Protein engineering with bacterial display. Curr Opin Struct Biol (2007) 1.27
Inclusion body formation and protein stability in sequence variants of interleukin-1 beta. J Biol Chem (1993) 1.21
Post-genomic vaccine development. FEBS Lett (2006) 1.17
Protein engineering of disulfide bonds in subtilisin BPN'. Biochemistry (1989) 1.15
Search for allosteric disulfide bonds in NMR structures. BMC Struct Biol (2007) 1.15
Thermostabilization of the Bacillus circulans xylanase by the introduction of disulfide bonds. Protein Eng (1994) 1.14
Stabilization of functional proteins by introduction of multiple disulfide bonds. Methods Enzymol (1991) 1.14
Stabilization of an immunoglobulin fold domain by an engineered disulfide bond at the buried hydrophobic region. J Biol Chem (2007) 1.11
Disulfide bonds and thermal stability in T4 lysozyme. Proc Natl Acad Sci U S A (1988) 1.11
Improved stability of a protein vaccine through elimination of a partially unfolded state. Protein Sci (2004) 1.10
Rapid crystallization of T4 lysozyme by intermolecular disulfide cross-linking. Protein Eng (1994) 1.09
Selection of mutations for increased protein stability. Curr Opin Biotechnol (2002) 1.05
Engineered disulfide bonds in staphylococcal nuclease: effects on the stability and conformation of the folded protein. Biochemistry (1996) 0.94
Dramatic stabilization of the native state of human carbonic anhydrase II by an engineered disulfide bond. Biochemistry (2002) 0.94
Engineering a disulfide bond in recombinant manganese peroxidase results in increased thermostability. Biotechnol Prog (2000) 0.94
Calculation of protein heat capacity from replica-exchange molecular dynamics simulations with different implicit solvent models. J Phys Chem B (2008) 0.94
Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma. Ann Oncol (2003) 0.92
Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations. Vaccine (1998) 0.92
Introduction of a disulfide bond into ricin A chain decreases the cytotoxicity of the ricin holotoxin. J Biol Chem (1994) 0.90
Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant. Vaccine (2005) 0.87
The effect of engineered disulfide bonds on the stability of Drosophila melanogaster acetylcholinesterase. BMC Biochem (2006) 0.87
Tomato bushy stunt virus (TBSV), a versatile platform for polyvalent display of antigenic epitopes and vaccine design. Virology (2009) 0.86
PFA, a novel mollusk agglutinin, is structurally related to the ribosome-inactivating protein superfamily. Arch Biochem Biophys (2001) 0.82
Enhancement of thermostability and catalytic efficiency of AprP, an alkaline protease from Pseudomonas sp., by the introduction of a disulfide bond. Biochem Biophys Res Commun (1996) 0.81
Peptide analogues of a T-cell epitope of ricin toxin A-chain prevent agonist-mediated human T-cell response. Int Immunol (2005) 0.79
Rational introduction of disulfide bond to enhance optimal temperature of Lipomyces starkeyi alpha-dextranase expressed in Pichia pastoris. J Microbiol Biotechnol (2009) 0.78
Coarse-grained lattice model simulations of sequence-structure fitness of a ribosome-inactivating protein. Biopolymers (2008) 0.76
An efficient hybrid explicit/implicit solvent method for biomolecular simulations. J Comput Chem (2004) 2.40
Evaluation of Poisson solvation models using a hybrid explicit/implicit solvent method. J Phys Chem B (2005) 2.31
Calculation of absolute protein-ligand binding affinity using path and endpoint approaches. Biophys J (2005) 1.65
Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A. Bioorg Med Chem (2005) 1.30
Finding a new vaccine in the ricin protein fold. Protein Eng Des Sel (2004) 1.29
Mechanically bonded macromolecules. Chem Soc Rev (2009) 1.23
Improved stability of a protein vaccine through elimination of a partially unfolded state. Protein Sci (2004) 1.10
Potent new small-molecule inhibitor of botulinum neurotoxin serotype A endopeptidase developed by synthesis-based computer-aided molecular design. PLoS One (2009) 1.07
Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS. Vaccine (2011) 1.03
Small-molecule inhibitor leads of ribosome-inactivating proteins developed using the doorstop approach. PLoS One (2011) 1.01
Robust dynamics. Nat Chem (2010) 1.00
Dynamic hook-and-eye nanoparticle sponges. Nat Chem (2009) 1.00
Computer-aided lead optimization: improved small-molecule inhibitor of the zinc endopeptidase of botulinum neurotoxin serotype A. PLoS One (2007) 0.98
Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity. Protein J (2008) 0.96
Metal nanoparticles functionalized with molecular and supramolecular switches. J Am Chem Soc (2009) 0.95
Calculation of protein heat capacity from replica-exchange molecular dynamics simulations with different implicit solvent models. J Phys Chem B (2008) 0.94
Structure of RiVax: a recombinant ricin vaccine. Acta Crystallogr D Biol Crystallogr (2011) 0.93
Acid-base actuation of [c2]daisy chains. J Am Chem Soc (2009) 0.93
Structural characterization and reversal of the natural organophosphate resistance of a D-type esterase, Saccharomyces cerevisiae S-formylglutathione hydrolase. Biochemistry (2008) 0.90
Adjustment of codon usage frequencies by codon harmonization improves protein expression and folding. Methods Mol Biol (2011) 0.89
Identification of small-molecule inhibitors of Yersinia pestis Type III secretion system YscN ATPase. PLoS One (2011) 0.89
Probing the donor and acceptor substrate specificity of the γ-glutamyl transpeptidase. Biochemistry (2012) 0.89
Small molecules showing significant protection of mice against botulinum neurotoxin serotype A. PLoS One (2010) 0.88
Comparison of immunoreactivity of staphylococcal enterotoxin B mutants for use as toxin surrogates. Anal Chem (2012) 0.88
Molecular-mechanical switching at the nanoparticle-solvent interface: practice and theory. J Am Chem Soc (2010) 0.87
Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors. Adv Virol (2011) 0.86
Histidine affinity tags affect MSP1(42) structural stability and immunodominance in mice. Biotechnol J (2011) 0.86
Linking sediment-charcoal records and ecological modeling to understand causes of fire-regime change in boreal forests. Ecology (2009) 0.85
Cholinesterases and the basal lamina at vertebrate neuromuscular junctions. Curr Opin Pharmacol (2009) 0.85
Bis-imidazoles as molecular probes for peripheral sites of the zinc endopeptidase of botulinum neurotoxin serotype A. Bioorg Med Chem (2006) 0.84
Integrated bioassays in microfluidic devices: botulinum toxin assays. J Biomol Screen (2005) 0.83
A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol (2014) 0.83
3-substituted indole inhibitors against Francisella tularensis FabI identified by structure-based virtual screening. J Med Chem (2013) 0.83
Comparison of two adaptive temperature-based replica exchange methods applied to a sharp phase transition of protein unfolding-folding. J Chem Phys (2011) 0.83
Calculation of absolute ligand binding free energy to a ribosome-targeting protein as a function of solvent model. J Phys Chem B (2008) 0.83
Structural and mutational analysis of a monomeric and dimeric form of a single domain antibody with implications for protein misfolding. Proteins (2014) 0.83
Structural insight into exosite binding and discovery of novel exosite inhibitors of botulinum neurotoxin serotype A through in silico screening. J Comput Aided Mol Des (2014) 0.82
Fragment-based identification of determinants of conformational and spectroscopic change at the ricin active site. BMC Struct Biol (2007) 0.82
A neutral molecule in a cation-binding site: specific binding of a PEG-SH to acetylcholinesterase from Torpedo californica. J Mol Biol (2002) 0.82
Fold prediction of VP24 protein of Ebola and Marburg viruses using de novo fragment assembly. J Struct Biol (2009) 0.80
Conformational energy landscape of the acyl pocket loop in acetylcholinesterase: a Monte Carlo-generalized Born model study. Biophys Chem (2004) 0.80
Comparison of volume and surface area nonpolar solvation free energy terms for implicit solvent simulations. J Chem Phys (2013) 0.79
Donor-acceptor oligorotaxanes made to order. Chemistry (2011) 0.79
Modular synthesis and dynamics of a variety of donor-acceptor interlocked compounds prepared by click chemistry. Chem Asian J (2007) 0.78
Prediction of the multimeric assembly of staphylococcal enterotoxin A with cell-surface protein receptors. J Mol Graph Model (2003) 0.77
A reaction path study of the catalysis and inhibition of the Bacillus anthracis CapD γ-glutamyl transpeptidase. Biochemistry (2014) 0.77
Disruption of the putative vascular leak peptide sequence in the stabilized ricin vaccine candidate RTA1-33/44-198. Toxins (Basel) (2013) 0.76
Arranging pseudorotaxanes octahedrally around [60]fullerene. Chem Commun (Camb) (2010) 0.76
Free-energy profiles of membrane insertion of the M2 transmembrane peptide from influenza A virus. Biophys J (2008) 0.76
Highly stable tetrathiafulvalene radical dimers in [3]catenanes. Nat Chem (2010) 0.76
Isolation by crystallization of translational isomers of a bistable donor-acceptor [2]catenane. Proc Natl Acad Sci U S A (2010) 0.75
A role for His-160 in peroxide inhibition of S. cerevisiae S-formylglutathione hydrolase: evidence for an oxidation sensitive motif. Arch Biochem Biophys (2012) 0.75
Rapid thermally assisted donor-acceptor catenation. Chem Commun (Camb) (2012) 0.75
Rim-Differentiated C5-Symmetric Tiara-Pillar[5]arenes. J Am Chem Soc (2017) 0.75
Rapid and Efficient Removal of Perfluorooctanoic Acid from Water with Fluorine-Rich Calixarene-Based Porous Polymers. ACS Appl Mater Interfaces (2020) 0.75
A multistate switchable [3]rotacatenane. Chemistry (2011) 0.75
Validation of ELISA for the determination of anti-ricin immunoglobulin G concentration in mouse sera. Biologicals (2005) 0.75
Parallel Tempering of Dark Matter from the Ebola Virus Proteome: Comparison of CHARMM36m and CHARMM22 Force Fields with Implicit Solvent. J Chem Inf Model (2017) 0.75